Loading clinical trials...

Repetitive Transcranial Magnetic Stimulation in SCA3 Patients | Clinical Trials | Clareo Health

COMPLETEDNANCT05502432

Repetitive Transcranial Magnetic Stimulation in SCA3 Patients

Machado-Joseph Disease (MJD) or spinocerebellar ataxia type 3 (SCA3) is the most common spinocerebellar ataxia worldwide.Repetitive transcranial magnetic stimulation (rTMS) is a form of brain stimulat...

Lead sponsor: Ning Wang, MD., PhD.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1/2

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

NCT05822908 · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, and more

WITHDRAWNPhase 2

Study of CAD-1883 for Spinocerebellar Ataxia

NCT04301284 · Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1, and more

WITHDRAWNPhase 2

Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3

NCT01096095 · Spinocerebellar Ataxia Type 3

COMPLETEDPhase 2

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

NCT00992771 · Spinocerebellar Ataxia Type 3

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 16, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment39

Start dateDec 2018

Last updatedAug 16, 2022

Condition

Spinocerebellar Ataxia Type 3

Locations shown

Department of Neurology ,First Affiliated Hospital Fujian Medical University

Fuzhou, Fujian

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 16, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions